BRIEF-GSK receives US approval for diabetes treatment Tanzeum
April 15, 2014 at 13:06 PM EDT
* GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum Tm (Albiglutide)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.